🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open label Phase II study to determine the rate of improvement i...
Status
Completed
Location
University of Maryland Medical Center - M & S Greenebaum Cancer Center
Start Date
2010-11
Trial ID
NCT01242930
Treatments Being Tested
For each subject the study will consist of two phases: a treatment phase an...
Status
Completed
Location
Palo Verde Hematology Oncology
Start Date
2003-07-01
Trial ID
NCT00065351
Treatments Being Tested
This is a Phase 1a/1b, multicenter, open-label, two-part study in subjects ...
Status
Completed
Location
The University of Texas MD Anderson Cancer Center
Start Date
2015-10-19
Trial ID
NCT02426723
Treatments Being Tested
RATIONALE: Lenalidomide may stop the growth of tumor cells by blocking bloo...
Status
Terminated
Location
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
Start Date
2009-10
Trial ID
NCT01126450
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of SCTB35 ...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2026-06-09
Trial ID
NCT07562022
Treatments Being Tested
The purpose of this study is to determine the efficacy of Lenalidomide/Dexa...
Status
Completed
Location
Local Institution
Start Date
2015-02-20
Trial ID
NCT02272803
Treatments Being Tested
This is an open-label, multicentre, dose escalation study to characterize t...
Status
Completed
Location
AKH (Allgemeines Krankenhaus der Stadt Wien), Abteilung für Klinische Onkologie, Universitätsklinik für Innere Medizin I
Start Date
2011-07
Trial ID
NCT01421186
Treatments Being Tested
The Total Therapy treatment regimens developed at the Myeloma Institute hav...
Status
Withdrawn
Location
University of Arkansas for Medical Sciences
Start Date
2017-10-01
Trial ID
NCT03168100
Treatments Being Tested
This is a randomized, open label, multicenter phase III trial comparing the...
Status
Completed
Location
Moores UC San Diego Cancer Center
Start Date
2019-05-09
Trial ID
NCT03570892
RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer cell ...
Status
Terminated
Location
Haukeland Hospital - University of Bergen
Start Date
2011-02-09
Trial ID
NCT01307605
Treatments Being Tested